FACULTY
Marco Ruella, MD
Assistant Professor of Medicine
Scientific Director
Lymphoma Program Division of Hematology and Oncology
Philadelphia, PA
PROGRAM OVERVIEW
This enduring activity provides healthcare providers with a comprehensive educational experience focused on advancing the management of non-Hodgkin lymphoma (NHL) through antibody therapies. Participants will assess the clinical need to incorporate innovative treatments, including bispecific antibodies, into NHL care. The activity will explore the latest efficacy and safety data guiding the use of these therapies and delve into the identification of potential adverse events. Additionally, it will outline best practices for monitoring and managing these risks, equipping providers with the knowledge and tools necessary to optimize patient outcomes and enhance the quality of NHL care.
TARGET AUDIENCE
This activity is designed to meet the educational needs of medical oncologists, hematologists, nurse practitioners, pharmacists, and other members of the multi-disciplinary oncology care team.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the need to integrate antibody therapies, including bispecific antibodies, into NHL management.
- Discuss the latest efficacy and safety data guiding the utilization of antibody therapeutics, such as bispecific antibodies, in NHL.
- Recognize potential adverse events linked with antibody therapeutics for NHL and outline best practices for monitoring and managing these adverse events.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.25 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
| Faculty | Relationship | Manufacturer |
| Marco Ruella, MD | Consultant | glg, guidepoint |
| Contracted Research | Abclon, CURIOX, Beckman, Lumicks | |
| Stock | Vittoria biotherapeutics |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Michael Page, PharmD, RPh, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator, has nothing to disclose.
- Naomi De Brito, Program Manager for Med Learning Group, has nothing to disclose.
- A reviewer from CME Peer Review, LLC., has nothing to disclose.
- Kelly Vicci, RN, BSN, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (dietary, physical, etc). Please contact Med Learning Group prior to the live event at [email protected]
RELEASED DATE: January 24, 2025
EXPIRATION DATE: January 24, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
